Clinical Trial Update: GSK2190915 Pediatric Study [Phase 2]

View source ↗

Summary

A pediatric Phase 2 study of GSK2190915 for asthma has been withdrawn from the clinical trial program.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• GSK2190915

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 2 | Status: WITHDRAWN